Expression of peroxiredoxins i and IV in multiple myeloma: Association with immunoglobulin accumulation

Virchows Archiv

Volumn 463, Issue 1, 2013, Pages 47-55

  Demasi, Ana Paula Dias ^a   Martinez, Elizabeth Ferreira ^a   Napimoga, Marcelo Henrique ^a   Freitas, Leandro Lopes ^b   Vassallo, Jose ^b   Duarte, Adriana Silva Santos ^b   Soares, Andresa Borges ^a   Araujo, Ney Soares ^a   Araujo, Vera Cavalcanti ^a  

^a SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

B cell malignancies; Multiple myeloma; Oxidative stress; Peroxiredoxins; Unfolded protein response

Indexed keywords

HYDROGEN PEROXIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN LIGHT CHAIN; MESSENGER RNA; PEROXIREDOXIN 1; PEROXIREDOXIN 4;

ADULT; ARTICLE; B LYMPHOCYTE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELOMA CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; TISSUE SECTION; WESTERN BLOTTING;

CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENDOPLASMIC RETICULUM; HUMANS; HYDROGEN PEROXIDE; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; MULTIPLE MYELOMA; PEROXIREDOXINS; TRANSCRIPTION FACTORS;

EID: 84879838400     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-013-1433-1     Document Type: Article

References (27)

1. Harris NL (2001) Mature B-cell neoplasms: introduction. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization classification of tumors. Pathology and genetics of tumors of the haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 119-126
2. Shaffer AL, Rosenwald A, Staudt LM (2002) Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol 2:920-932
3. Gross E, Sevier CS, Heldman N, Vitu E, Bentzur M, Kaiser CA, Thorpe C, Fass D (2006) Generating disulfides enzymatically: reaction products and electron acceptors of the endoplasmic reticulum thiol oxidase Ero1p. Proc Natl Acad Sci U S A 103:299-304
4. Shimizu Y, Hendershot LM (2009) Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species. Antioxid Redox Signal 11:2317-2331
5. Kim I, Xu W, Reed JC (2008) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 7:1013-1103
6. Nakamura M, Gotoh T, Okuno Y, Tatetsu H, Sonoki T, Uneda S, Mori M, Mitsuya H, Hata H (2006) Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. Leuk Lymphoma 47:531-539
7. Obeng EA, Carlson LM, Gutman DM, Harrington WJ Jr, Lee KP, Boise LH (2006) Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 107:4907-4916
8. Kang SW, Rhee SG, Chang TS, Jeong W, Choi MH (2005) 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol Med 11:571-578
9. 2, and protein chaperones. Antioxid Redox Signal 15:781-794
10. Bertolotti M, Yim SH, Garcia-Manteiga JM, Masciarelli S, Kim YJ, Kang MH, Iuchi Y, Fujii J, Vené R, Rubartelli A, Rhee SG, Sitia R (2010) B- to plasma-cell terminal differentiation entails oxidative stress and profound reshaping of the antioxidant responses. Antioxid Redox Signal 13:1133-1144
11. Demasi AP, Ceratti D, Furuse C, Cury P, Junqueira JL, Araujo VC (2007) Expression of peroxiredoxin I in plasma cells of oral inflammatory diseases. Eur J Oral Sci 115:334-337
12. Demasi AP, Magalhães MH, Furuse C, Araújo NS, Junqueira JL, Araújo VC (2008) Peroxiredoxin I is differentially expressed in multiple myelomas and in plasmablastic lymphomas. Oral Dis 14:741-746
13. Stein H, Delsol G, Pileri S, Said J (2001) Hodgkin Lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization classification of tumors. Pathology and genetics of tumors of the haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 237-253
14. Brunning RD, Borowitz M, Matutes E, Head D, Flandrin G, Swerdlow SH, Bennett JM (2001) Precursor B lymphoblastic leukemia/lymphoblastic lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization classification of tumors. Pathology and genetics of tumors of the haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 111-114
15. Grogan TM, Camp BV, Kyle RA, Müller-Hermelink HK, Harris NL (2001) Plasma cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization classification of tumors. Pathology and genetics of tumors of the haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 142-151
16. Greenstein S, Krett NL, Kurosawa Y, Ma C, Chauhan D, Hideshima T, Anderson KC, Rosen ST (2003) Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells. Exp Hematol 31:271-282
17. Marshall-Taylor CE, Cartun RW, Mandich D, DiGiuseppe JA (2002) Immunohistochemical detection of immunoglobulin light chain expression in B-cell non-Hodgkin lymphomas using formalin-fixed, paraffin-embedded tissues and a heat-induced epitope retrieval technique. Appl Immunohistochem Mol Morphol 10:258-262
18. Tavender TJ, Bulleid NJ (2010) Peroxiredoxin IV protects cells from oxidative stress by removing H2O2 produced during disulphide formation. J Cell Sci 123:2672-2679
19. Tavender TJ, Springate JJ, Bulleid NJ (2010) Recycling of peroxiredoxin IV provides a novel pathway for disulphide formation in the endoplasmic reticulum. EMBO J 29:4185-4197
20. Zito E, Melo EP, Yang Y, Wahlander Å, Neubert TA, Ron D (2010) Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin. Mol Cell 40:787-797
21. Balague O, Mozos A, Martinez D, Hernandez L, Colomo L, Mate JL, Teruya-Feldstein J, Lin O, Campo E, Lopez-Guillermo A, Martinez A (2009) Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications. Am J Pathol 174:2337-2346
22. Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, Friend D, Grusby MJ, Alt F, Glimcher LH (2001) Plasma cell differentiation requires the transcription factor Xbp-1. Nature 412:300-307
23. Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH, Qian SB, Zhao H, Yu X, Yang L, Tan BK, Rosenwald A, Hurt EM, Petroulakis E, Sonenberg N, Yewdell JW, Calame K, Glimcher LH, Staudt LM (2004) Xbp1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21:81-93
24. Munshi NC, Hideshima T, Carrasco D, Shammas M, Auclair D, Davies F, Mitsiades N, Mitsiades C, Kim RS, Li C, Rajkumar SV, Fonseca R, Bergsagel L, Chauhan D, Anderson KC (2004) Identification of genes modulated in multiple myeloma using genetically identical twin samples. Blood 103:1799-1806
25. Carrasco DR, Sukhdeo K, Protopopova M, Sinha R, Enos M, Carrasco DE, Zheng M, Mani M, Henderson J, Pinkus GS, Munshi N, Horner J, Ivanova EV, Protopopov A, Anderson KC, Tonon G, DePinho RA (2007) The differentiation and stress response factor Xbp-1 drives multiple myeloma pathogenesis. Cancer Cell 11:349-360
26. Teng Y, Takahashi Y, Yamada M, Kurosu T, Koyama T, Miura O, Miki T (2007) IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells. Eur J Cell Biol 86:581-589
27. Celada A, McKercher S, Maki RA (1993) Repression of major histocompatibility complex IA expression by glucocorticoids: the glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein. J Exp Med 177:691-698